A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast…

Overview of attention for article published in Trials, June 2016

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 78 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 8,229 followers.

$MDVN A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib...https://t.co/67aG0u13wi https://t.co/C9K6eoBGZ5

Reply Repost Favourite

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by… https://t.co/mGsIxNJVlH #breastcancer

Reply Repost Favourite

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by… https://t.co/abdNmoeuhy #breastcancer

Reply Repost Favourite

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by… https://t.co/C5ZAdhUtce #breastcancer

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.